Actually, I think this is good news because Agritek and its management absolutely sucks and I couldn't understand why in the hell Mark would go into business with these people. I've been wondering if maybe they got a bunch of PNTV shares up front and they're the ones doing all this damn selling. Either way, this whole thing stinks to me.

Why wasn't the following ever reported by PNTV? This is from Agritek in an 8K on June 4th.

Item 8.01. Other Events.



On March 23, 2015, the Company announced the execution of a Master Consulting Financing & Licensing Agreement (the “Agreement”) with Green Leaf Farms Holdings Inc. (“Green Leaf”) an 80% owned subsidiary of Players Network, a fully reporting diversified company with holdings in two primary areas, Media and Medical Marijuana. In the Agreement, executed by Green Leaf, Green Leaf stated it had signed a five (5) year lease agreement with two five (5) year options, with a third party to the real property located at 203 Mayflower, North Las Vegas. Based on the forgoing, the Company had agreed to provide certain consulting and financings to Green Leaf and/or Players Network, for the property that Green Leaf was leasing from the third party. After both parties executed the Agreement, the Company had discovered that Green Leaf’s lease for the Mayflower address is for three years without any renewal options and therefore was not consistent with the executed Agreement. Accordingly, based on this misrepresentation from Green Leaf, the Company is terminating the Agreement and has no obligations under the Agreement. In the termination letter sent to Green Leaf and Players Network, the Company has reserved all of its’ legal rights for damages caused to the Company pursuant to the breach described above.

Don't get me wrong odie. I think the company is in great shape now with a great product that I always believed in. The first RS was done at the wrong time and they didn't have the financial numbers to make it work so the stock price tumbled. This time may be different and the leadership in place now has to show that they have the numbers to justify the stock price. It's just that two reverse splits put my cost basis way too high. Very few companies can make an RS work. They just use them to keep financing themselves on the backs of the shareholders, especially in the OTC stocks. CYRX has to get off the OTC and have the income to support the stock price. We shall see.

Well I've been in this stock for 7 years. Just been sitting on the sidelines quietly waiting. Read this board all the time but haven't posted in ages. Suffered through the first reverse split but managed to average down some and kept hoping to one day get my money back. This second reverse split is the final nail in the coffin for me. It puts my average way too high this time. I sold out today and will take my losses. I swore to never sit through another RS again and I won't. Now it seems that every time I buy a stock it goes down and when I sell it goes up, so you folks will probably make out OK and I wish you all the best of luck with this.
CYRX has come a long way and is looking way way better now but just not for me anymore. Good Luck All !!!

Nov. 18, 2013 13:00 UTC
Cryoport Revenues Increased 151% for the First Half of Fiscal 2014
Market acceptance gaining traction

LAKE FOREST, Calif.--(BUSINESS WIRE)-- Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the quarter and six months ended September 30, 2013.

Net revenues were $1,067,790 for the six months ended September 30, 2013, as compared to $424,896 for the six months ended September 30, 2012. The $642,894 growth, or 151% increase, was primarily driven by Cryoport’s Integrated Solution and overall growth in the number of customers using Cryoport Express® Solutions compared to the same period in the prior year.

Gross margin for the six months ended September 30, 2013 was 12% of net revenues, or $126,744, as compared to a gross loss of 64% of net revenues, or $273,162, for the six months ended September 30, 2012. Cost of revenues for the six months ended September 30, 2013 was 88% of net revenues, or $941,046, representing Cryoport’s first positive gross margin. This compared to cost of revenues of 164% of net revenues, or $698,058, for the six months ended September 30, 2012.

Cryoport’s Chief Executive Officer, Jerrell Shelton, commented, “I'm pleased to report continued revenue growth and a positive gross profit for the quarter and the first half of our fiscal year. Our sales and marketing strategies are gaining momentum as evidenced by our reported revenue and continue to be fueled by a very active and growing sales pipeline. In addition, we continue to move forward with our ‘powered by CryoportSM’ partnering strategy designed to expand our sales and marketing reach as well as to increase the awareness of our solutions in the life sciences community. More and more companies have started relying on our validated and technology-centric solutions and expertise in time- and temperature-sensitive logistics. We now have experienced eight consecutive quarters of revenue growth and expect to further accelerate our sales trajectory as implied by our current momentum.

“Moving forward, we will maintain our long-term view of the market opportunity and stay true to our strategic plan. Our goal is to be the leading provider of logistics services to the life sciences industry. We are successfully transitioning from a ‘one service fits all’ approach to being a logistics solutions company developing customized plans to meet client-defined needs. In addition to sales of our basic turnkey solution, our customer-integrated solution is being particularly well received, and we also have customers utilizing our customer-staged, customer-managed, and distribution partner models. In fact, we are experiencing increased attention from integrators, specialty couriers, and freight forwarders, which provides us with additional opportunities for revenue producing partnerships. We have doubled our customer base over the past six months and are in the early adaption stages with a significant number of larger life sciences companies. Revenues related to reproductive medicine, in-vitro fertilization, in particular, are increasing, as is our animal husbandry business.

"During this current fiscal 2014 and beyond, I believe we can drive shareholder value by becoming even more effective in increasing market awareness, closing sales, serving customer needs, efficiently managing expenses, and prudently investing capital in support of our growth plans. The Cryoport team is motivated for success.”

Just took a look at Marvin Traub & Associates. Poor ole Marvin passed away a year ago and now Mortimer is in charge. Also saw that Kenny hired his worthless son Brian as vice president. Nepotism is alive and well. Hey Mortimer--Do you even know anything at all about these idiots you hired?? It'll be down hill from now on at Traub & Associates Beverage Division.

So Kenny is now Managing Director Consumer Food and Beverage Marvin Traub Associates and he hires ole Charles Davidson as Vice President at Traub Consumer Food and Beverage. I guess this Marvin Traub must not of looked into what those assholes did to Dkam. Next thing you know Kenny will hire his daughter Cristine who was on the payroll for 4 years at Dkam and was another waste of space. It's a damn shame what that fat pos did to this company and all the shareholders. Watch out Traub you dumb ass!!!!

Cryoport, Inc. (OTCBB: CYRX) today announced preliminary financial results for the fiscal fourth quarter and year ended March 31, 2013. Revenues for fiscal 2013 were $1.1 million, an increase of 98%, compared with revenues of $556,000 in fiscal 2012. Operating expenses in fiscal 2013 were $5.8 million, down 12%, compared with operating expenses of $6.6 million in fiscal 2012. Excluding stock-based expenses, operating expenses in fiscal 2013 were $5.1 million, down 15%, compared with $6.0 million in fiscal 2012. The net loss in fiscal 2013 was $6.4 million, compared with a net loss of $7.8 million in fiscal 2012.

In the fourth quarter of fiscal 2013 revenues were $368,000, up 108%, compared with revenues of $177,000 in the fourth quarter of fiscal 2012.

Cryoport’s Chief Executive Officer, Jerrell Shelton, commented, “I'm pleased to report that in fiscal 2013, we moved forward on all fronts. We are seeing the beginning of the positive impact of our expanded customer-centric business model offering a full range of cold chain logistics solutions. Sales growth accelerated throughout fiscal 2013 due to consistent performance from our sales team and some large client wins. We have had six consecutive quarters of revenue growth, doubled our customer base over the past twelve months, continued to penetrate the In Vitro Fertilization market, and are expanding partnerships to extend Cryoport’s sales and marketing reach. Those trends are continuing in fiscal 2014, and based on our current annualized revenue run rate of $1.8 million, planning discussions with clients, and the eventual raising of additional capital, we expect revenue in fiscal 2014 to grow at an accelerated pace.

“Moving forward, we will maintain our long-term view of the market opportunity and stay true to our strategic plan. Our goal is to be the leading provider of logistics services to the biotech and life sciences industries. We are successfully transitioning from a ‘one service fits all’ approach to being a logistics solutions company developing customized plans to meet client-defined needs. In addition to sales of our basic turnkey solution, our customer-integrated solution is being particularly well received, and we also have customers utilizing our customer-staged, customer-managed, and distribution partner models. We are experiencing increased attention from integrators and freight forwarders, which provides us with additional opportunities for revenue producing partnerships. We are also in the early stages of making inroads into animal husbandry.

"In fiscal 2014 and beyond, I believe we can drive shareholder value by becoming even more effective in increasing market awareness, serving customer needs, efficiently managing expenses, and prudently investing capital raised in support of our growth plans. The Cryoport team is motivated for success.”

Robert Stefanovich, Chief Financial Officer, said, "In addition to our new customer growth, our fiscal 2013 results reflect our diligence on the management of expenses. We are continually examining all opportunities to better align our costs with revenue generation.”
The Company intends to report full financial results for fiscal 2013 on Form 10K during the last week of June 2013.

Still hanging around staying out of trouble waiting for this thing to makes its move one day. Hope it won't be much longer so I'm still alive to spend my Long Term capital gains.

I don't know why this bankruptcy crap came up because Menzies has come on board. The last three companies he was associated with are still in business, so he wasn't there to handle any bankruptcies and I don't see why he would come to Dkam for that reason. It looks to me like he's here to handle a restructuring of the company for the future which can be a good thing going forward.

I'm another shareholder that's been here a while, going on five years now. Can't hardly believe it's been that long. Suffered through two CEO's and a disaster of a reverse split, but I always believed in the technology and that it would someday replace dry ice shipping if this company could just hold on financially. This deal with Pfizer is just what we needed and we now have the management in place to go forward like never before. Very interested to see what kind of income we can expect from this. Like Baseball Fan said, Pfizer would not have committed to this without having confidence in Cryoport and their ability to handle this challenging undertaking. This deal is huge. What a relief!!

That was pretty good. Here's a quick link to the video by Cryoport about how to use the shipper--

The following is PK's Linked-in page that was recently updated
http://www.linkedin.com/profile/view?id=35275731&snapshotID=93141326&authType=name&authToken=wMWN&trk=EML_nus_prof-FBackfillKafkaConsumer&ut=2od5bAlSHoqRs1
What I find interesting is at the bottom where he just added that he went to West Point from 1974 to 1977. Graduates from there are obligated to serve 5 years in the army. PK was never in the military so I guess he didn't graduate or he really never went to West Point. Curious!

I fully understand the way you feel about PK and I'm sure many others feel the same way. The thing is now he is gone and we may have a chance for this company to be turned around. We can only hope for the best and see what happens I guess.

You're right. Make that 7:20 tonight for those of us on the east coast.http://redchip.com/visibility/conferencePages/SanFran2012/conferenceMain.asp?page=showschedule

Dkam gives it presentation today at 4:20 eastern.
http://redchip.com/visibility/conferencePages/SanFran2012/conferenceMain.asp?page=showschedule

FedEx Summit Spotlights “Borderless Healthcare”
October 04, 2012 10:00 AM Eastern Daylight Time
Healthcare Summit Highlights Future of the Industry in Increasingly Interconnected World; Company Showcases Updated Portfolio of FedEx Healthcare Solutions

MEMPHIS, Tenn.--(BUSINESS WIRE)--With a current world population of more than seven billion, and expectations that number will exceed eight billion by 2030, the global healthcare industry is growing exponentially. But to achieve its potential, providers across the industry—from R&D and manufacturing to the caregivers themselves—must go “borderless.” This interconnected view of the industry’s future was the focus of the FedEx Corp. (NYSE: FDX) healthcare industry summit, held in New York City this week.

“As research and manufacturing increase around the world, there’s a corollary demand for global healthcare services and solutions. FedEx offers the connectivity the healthcare industry needs to harness the power of that growth”

The conference featured presentations and discussions with FedEx leaders and external experts on the changing dynamics of the healthcare industry and the solutions it needs to grow for the future.

“As research and manufacturing increase around the world, there’s a corollary demand for global healthcare services and solutions. FedEx offers the connectivity the healthcare industry needs to harness the power of that growth,” said Frederick W. Smith, chairman, president and CEO of FedEx Corp.

While the United States currently accounts for healthcare growth, demand from developing markets like China and India will rise in line with their economies, making the healthcare sector’s ability to access and connect with these markets an imperative.

“As countries develop and populations expand, the market for our customers’ healthcare products and services grows right alongside,” said Richard W. Smith, director of Life Sciences and Specialty Services, FedEx Express. “We know that the right mix of efficient supply chain solutions will be a critical underpinning to this growth for years to come. That’s why FedEx has dedicated time, money and man-power to build out a portfolio of products and services specially designed to fit the needs of our healthcare customers. From innovations in cold chain technology to increasing the speed and reach of our temperature-controlled shipping capabilities, FedEx is a leader in transporting critical healthcare inventory around the world.”

In addition to opening remarks provided by FedEx Chairman and CEO Frederick W. Smith, FedEx Chief Economist Gene Huang weighed in on the current economic state of the global healthcare market and future projections, while FedEx Express Chief Operating Officer Mike Ducker shared his view on global logistics advancements and trends that make a borderless healthcare industry viable. Global Sales Executive Vice President Don Colleran expanded on the new FedEx solutions available to customers, while Global Marketing Senior Vice President Raj Subramaniam rounded out the conference with a panel discussion featuring FedEx leaders discussing healthcare trends occurring across the globe.

FedEx product enhancements showcased for customers throughout the summit included:

SenseAware: The next generation of this award-winning sensor-based technology is now available for general use. Upgrades include improved GPS capabilities and cellular connectivity, as well as increased battery life to support longer transit times. New accessories such as the dry ice probe, among others, are increasing the effectiveness of SenseAware to help customers monitor their most critical shipments.
FedEx Priority Alert: This service, previously only available on domestic U.S. shipments, is now being rolled out on a broad scale. Beginning in October 2012, contract customers shipping to and from more than 70 international markets will have access to the increased monitoring and proactive intervention services of Priority Alert. The healthcare industry specifically benefits from the expansion, as the specialized services of FedEx Priority Alert Plus include recovery actions, such as dry ice replenishment, gel pack reconditioning and access to cold storage to help keep potentially life-saving shipments safe.
FedEx Deep Frozen Shipping: FedEx makes the transportation of deep-frozen material simpler than ever before, eliminating the need for dry ice or expensive rented shipping equipment. This value-add FedEx service provides customers dealing with deep frozen material—such as body fluids, tissue samples or medicines—with a ready-to-ship, super-cooled Dewar that holds a temperature below minus-150 degrees Celsius for up to 10 days. Dry ice, in contrast, must be replenished every 72 hours to maintain its temperature. Eliminating the need for dry ice also reduces customs clearance delays and helps ensure sensitive deliveries arrive on time and in pristine clinical condition.

Three Months Ended July 31, 2012 Compared to Three Months Ended July 31, 2011

Net Sales: Net sales were approximately $1,290,000 for the three months ended July 31, 2012 compared to net sales of approximately $148,000 for the same period last year, an increase of 771% as a result of the Company’s sales of products from the Drinks WBI transaction and the companies access to production credit that arises from the deal whereby the company is no longer impeded from production limited by access to capital. The company’s KAH Tequila is the primary driver of revenue growth for the company.

Gross Margin: Gross margin was $293,157, or 22.7% of net sales for the three months ended July 31, 2012 compared to gross margin of $15,298, or 10.3% of net sales for the three months ended July 31, 2011.

Selling, General and Administrative Expenses: Selling, general and administrative expenses totaled approximately $701,000 for the three months ended July 31, 2012, compared to $514,000 for the three months ended July 31, 2011, an increase of approximately $187,000, or 36.4%, attributable to additional selling costs due increased sales volumes.

Interest expense: Interest expense for the three months ended July 31, 2012 was approximately $30,000 compared to $112,000 for the same period last year, a net decrease of $82,000 or 73%. This decrease is predominantly due to our access to production through our WBI transaction and a reduction in the cost of financing our outstanding liabilities as compared to prior year.

Loss on change in fair value of derivative: During the three months ended July 31, 2011, we were required to bifurcate the conversion option embedded in certain convertible promissory notes and record at fair value each reporting period as a liability. During the three months ended July 31, 2011, we recorded a loss on change in fair value of $29,384 as compared to Nil the same period current year.

Loss (gain) on settlement of debt: During the three months ended July 31, 2012, we negotiated and settled outstanding debt, primarily trade vendors. As such, we recognized a loss on settlement of debt of approximately $500 for the three months ended July 31, 2012 compared to a gain of approximately $18,000 the same period last year.

Gain on disposal of product line: During the three months ended July 31, 2011, we exchanged 42% of our interest in Olifant U.S.A, Inc. for the cancellation of our remaining outstanding debt obligation and related accrued interest. With the exchange, we reduced our ownership to 48% and realized a gain on sale of the product line of approximately $280,478 compared to Nil for the three months ended July 31, 2012.
Financial Liquidity and Capital Resources

Our accompanying consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern. As of July 31, 2012, the Company has shareholders' equity of approximately $1,690,000 applicable to controlling interests compared with $2,108,000 applicable to controlling interests at April 30, 2012, and working capital deficiency of approximately $3,650,000 as of July 31, 2012 and has incurred significant operating losses and negative cash flows since inception. For the three months ended July 31, 2012, the Company sustained an operating loss of approximately $408,000 compared to an operating loss of $499,000 for the three months ended July 31, 2011 and used cash of approximately $38,000 in operating activities for the three months ended July 31, 2012 compared with approximately $238,000 for the three months ended July 31, 2011. We have converted certain liabilities into equity. The accompanying consolidated financial statements do not include any adjustments relating to the classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the company be unable to continue in existence.

This sure has been a long slow uphill battle with this company, but it does seem they are finally getting a good handle on things and making some good adjustments toward a better business model. Another 18 months to be cash flow positive though doesn't sound great. If I ever make money on this it will definitely be long term capital gains for tax purposes.

I have to say I'm really glad to be rid of PK and I hope he takes his son with his "consulting job" with him. PK never gave a crap about the shareholders. He made sure to take care of himself any way he could at our expense. I have no idea what the Cabo boys will do with the company so I'll just hope for the best and see what happens.

More good news today. http://ih.advfn.com/p.php?pid=nmona&article=54156457

Cenetron Diagnostics Gains Better Control Of Temperature-Sensitive Shipments For Clinical Trials
Source: FedEx HealthCare Solutions

Cenetron Diagnostics, a premier provider of molecular laboratory services that support pivotal global trials for anti-viral and oncology drug development programs, was relying on costly premium carriers to ship temperature-sensitive clinical trial samples via dry ice all over the world. What the provider needed was a more efficient, cost-effective way to transport these specimens.

By switching to the FedEx® Deep Frozen Shipping Solution, Cenetron gained significantly more end-to-end visibility and control over these critical shipments. The provider simply enters the shipments into the FedEx Deep Frozen Shipping Solution online portal, and the pre-charged liquid nitrogen dry-vapor containers are delivered for shipment preparation the next day. Cenetron can also easily track the status of any shipment via FedEx InSight®.

Additionally, the customer now enjoys up to 10 days of holding time below 150°C for these clinical trial samples – which has eliminated the need to re-ice shipments every 2-3 days en route to international destinations. Perhaps more importantly, because the per-shipment cost of the FedEx Deep Frozen Shipping Solution is approximately 30 percent lower than the premium carriers’ rates, Cenetron has enjoyed a sizeable reduction in shipping expenses for these linical trial samples.

http://ll-media.tmz.com/2012/09/02/0902-gigolo-sub-1.jpg
That tequila bottle looks very familiar for some reason.
This was at a strip club called "Girls,Girls,Girls" in Vegas--a premier party for "Gigolos".

RedChip Announces Keynote Speaker for August Small-Cap Virtual Conference

RedChip Companies, Inc. ("RedChip"), an international, small-cap research and investor relations firm, today announced that David Riedel, an expert on emerging market investing, will deliver the keynote speech at the RedChip Small-Cap Virtual Conference on August 29-30, 2012. His presentation is titled "Investing in Emerging Markets: Avoiding Frauds and Uncovering Gems in the Global Emerging Markets."

Mr. Riedel is the founder and president of Riedel Research Group, a provider of independent equity research focusing on emerging markets in Asia, Latin America, and Europe. Previously, Mr. Riedel worked as an analyst at Salomon Smith Barney in New York and Bangkok. While in New York, he covered business services stocks, including staffing and outsourcing, as well as small-cap growth companies in the automobile and motorsports industries. While overseas, Mr. Riedel supervised a 12-person research team covering telecommunications companies and other industries in Southeast Asia. Mr. Riedel is the author of "Finding the Hot Spots: 10 Strategies for Global Investing" (Wiley, 2006). He is a frequent contributor to CNBC, Barron's, The Wall Street Journal, Bloomberg and other press outlets.

The RedChip Small-Cap Virtual Conference will feature executive presentations from 14 small-cap public companies. Each company will deliver a 30-minute investment-driven presentation followed by a 15-minute Q&A session. All presentations will be webcast live at http://www.RedChip.com and archived for a minimum of 30 days. Presenting companies include:

Asure Software, Inc. (Nasdaq:ASUR)
Galectin Therapeutics, Inc. (Nasdaq:GALT)
L & L Energy, Inc. (Nasdaq:LLEN)
MEDL Mobile Holdings, Inc. (OTCBB:MEDL)
Drinks Americas Holdings, Ltd. (OTCBB:DKAM)

Did everyone get their proxy information and send in their vote yet? I got mine a few days ago. Not much to it. I think it's time for some new blood on the board so I voted "no" on Michelin and Muller and "no" on the increase in the share count. The reverse split was a huge disaster and I can't see diluting the share count on top of that at this point. Just my opinion!!

I like this part--

"We have made only minor adjustments to our model following Q1 results and continue to model sequential revenue growth throughout the remainder of fiscal 2013. We are maintaining our Outperform rating and $3.00/share price target."

Drinks Americas Enters Into Letter of Intent to Purchase Worldwide Beverage Imports, LLC

Transaction Could Add $2mil in Incremental Revenue to Drinks Americas

RIDGEFIELD, CT, (DATE - PRNEWSWIRE) – Drinks Americas Holdings, Ltd., (“Drinks”) (OTCBB: DKAM), a leading developer and marketer of beverage products, announced today that it has entered into a letter of intent regarding the acquisition of Worldwide Beverage Imports, LLC (“WBI”) for approximately 1,000,000 shares of common stock of the Company in exchange for the assignment and assumption of the contract and sale rights to WBI’s licensed brands, WBI’s sales rights in California (the only territory not currently included in Drinks distribution agreement), WBI’s lease for warehouse facilities and a right of first refusal to purchase the assets of Fabrica de Tequilas Finos, S.A. de C.V. and Cerveceria Mexicana, S. de R.L. de C.V. and Cerveceria Azteca, S. de R.L. de C.V.

The immediate impact of the close of this transaction will be the addition of up to $2mil of tequila sales for Drinks Americas from the addition of California territory sales, which sales area not currently included in the scope of Drinks Americas’ global distribution and licensing contract with WBI.

Patrick Kenny, CEO of Drinks Americas stated, “If we close this transaction, it will have the immediate impact of potentially increasing our gross margins, enhancing our potential profitability and immediately adding up to $2mil in revenue from the additional California business to our National model. The overall transaction, once completed, will impact Drinks Americas’ size, scale, potential profitability, and will create a large west coast sales and distribution center.”

The final terms and conditions of the Transaction are being negotiated and will be determined in a definitive agreement. No assurances can be provided that a definitive agreement will be executed. Execution of a definitive agreement is subject to, among other things, the grant to the Company of a thirty day right of first refusal to purchase the assets of Fabrica de Tequilas Finos, S.A. de C.V. and Cerveceria Azteca, S. de R.L. de C.V., which right of first refusal shall expire twelve months from the date of the contemplated definitive agreement.

From the 10-Q http://sec.gov/Archives/edgar/data/700815/000114420412030754/v313988_10q.htm
On January 11, 2012, Asher converted $5,000 of its note and $2,120 in accrued interest into 569,600 shares of the Company’s common stock.



On January 24, 2012, Asher converted $12,000 of its note into 2,181,818 shares of the Company’s common stock.



On February 21, 2012, Asher converted $15,000 of its note into 2,678,571 shares of the Company’s common stock.



On March 12, 2012, Asher converted $13,000 of its note into 4,482,759 shares of the Company’s common stock.



All note conversions were within the terms of the agreement.



As a result of the above common stock issuances, there were 135,487,043 shares issued and outstanding as of March 31, 2012.

This is what's killing the shareholders. Financing the company with almost 28 million shares(previous OS was 107,685,367) that get dumped on the market when there are very few buyers around to absorb them. What the hell has our new marketing genius Ms Khieu been doing lately to earn her paycheck??

Sorry to see you go but I completely understand your reason. Ever since they decided to sell the fuel station and go off on this exploration kick it has been down hill. They tell us how important the shareholders are and their communications with us but it's all BS. They made stupid financing arrangements that cost all of us dearly. Try to communicate with them and you never get an answer. I'd go too but it's just not worth selling at this point. Good luck!!

Cryoport Teams with Pan Asia Logistics to Open Operations Center in Singapore.

Today : Wednesday 9 May 2012

Cryoport, Inc. (OTCBB: CYRX) today announced that it has signed an agreement with Pan Asia Logistics to open its Asian Operations Center in Singapore. The agreement calls for Pan Asia to support the Cryoport Solution by providing warehousing, shipping, receiving, order entry and fulfillment, and refurbishing and recycling of Cryoport’s liquid nitrogen dry vapor shipping containers.

“Shipments of life science and biological material are growing at a strong double digit growth rate in Asia, and our partnership with Pan Asia Logistics will significantly enhance our ability to expand our services within our current customer base and drive new business,” said Cryoport’s Chairman Stephen Wasserman. “Not only is Singapore the site of a growing number of clinical trials, it is also strategically located to serve as a hub for life science shipments across the continent and globally. Pan Asia is well known throughout the region, and its reputation for excellent customer service made it the best choice to help build our business in Asia.”

Pan Asia Logistics Executive Director Susan Tan stated, “Cryoport represents a significant advancement in frozen shipping for the life science industry, and is already incorporated into our operations. We are looking forward to providing the features and benefits of the Cryoport solution, including the highest standard of shipping integrity, ease-of-use, and environmental safeguards to life sciences companies in the Asia-Pacific region.”

If you read the sticky posts you can get an idea of what has happened to this company. As for those outrageous charges for legal, professional, and consulting charges maybe you can contact our new IR girl who has absolutely no experience in the oil and gas business and she can give you the answers. This dumbass we have for a CEO has acquired financing that has driven the stock down 90% and he loves to talk about shareholder value and communication but never answers email questions sent to him and has completely destroyed this stock. We are not happy campers over here 10 bagger!!

Is this fantastic or what??? Best damn Easter present we could have ever asked for!!! Mr. Wasserman is a good man and will make a great Chairman of the board and I'm sure he will be able to help find a new CEO who will run the company much much better than Larry ever did.

CryoPort Announces Resignation of Chairman and Chief Executive Officer Larry Stambaugh

Today : Friday 6 April 2012

CryoPort, Inc. (OTCBB: CYRX) today announced that its Board of Directors has accepted Larry Stambaugh’s resignation as the Company’s Chairman, Director and Chief Executive Officer, effective immediately.

Recently appointed Director Stephen E. Wasserman has been named Chairman, also effective immediately. In addition, the Board has formed an Office of the Chief Executive comprised of independent Directors to assume day-to-day management responsibilities of the Company on an interim basis, while the Board searches for a successor CEO.

“On behalf of the Board, I want to thank Larry for his dedication to CryoPort over the past three years, and for his efforts to advance the Company’s breakthrough CryoPort Express product and service offering,” said Mr. Wasserman.

It would appear that this is where Larry has been getting his new hires from. Keeping it in the family I guess. Doesn't look good there Larry. Just another reason to resign--Please Larry!!!!

Is this latest announcement a joke or what?? Seasoned marketing executive?? http://www.linkedin.com/in/narathkhieu She has zero experience in the oil and gas field. I have to believe one of our execs is dating this women as I see no other reason to hire her. Again they dish out more BS about shareholder value and importance while they continue with share destroying financing that has driven the stock to sub penny prices. What a bunch of crap!!!!!!

I figure Larry will have to take Leatherman over to the Netherlands for an all expenses paid trip to visit the MediRent operations center with maybe a little side trip around Europe for good measure to spend some more of that money we borrowed.

Well here we are just 2 cents from the 52 week low. What a great job our wonderful CEO is doing. Hey Larry--how about doing the right thing for the stock holders and follow Carlton out the door will ya?? You have completely failed at your job and it's time to quit stuffing your pockets with company cash. Please Please Resign for all our sakes.

CryoPort Names Stephen Wasserman to Board of Directors

Cryoport (OTCBB:CYRX)

Today : Thursday 29 March 2012

CryoPort, Inc. (OTCBB: CYRX) today announced that it has named Stephen E. Wasserman, 65, to its Board of Directors. Mr. Wasserman has more than 30 years of senior operating and financial management experience in the medical device and healthcare industries. He replaces Carlton M. Johnson, who resigned from the Board earlier this month.

“Stephen’s experience managing highly successful medical device and diagnostic companies will be extremely valuable to CryoPort as we accelerate our commercial activities this year,” said Larry Stambaugh, CryoPort’s chairman and chief executive officer. “We look forward to drawing on Stephen’s in-depth knowledge of our target markets and his proven ability to drive the introduction of new technologies and products.”

Mr. Wasserman is currently on the Board of the medical diagnostics firm Iris International, and serves as chairman of the compensation committee. Previously he served as group vice president of the Diagnostic Systems Products division of Olympus America, a leading medical technology company, as well as a member of the executive committee for American Operations. Earlier in his career he was chief financial officer and treasurer of Datascope Corporation, where he was also president of its Patient Monitoring Division, general manager for Melville Biologics, and vice president and general manager of Technicon (now part of Siemens Healthcare Diagnostics).

Mr. Wasserman received his Bachelor's in Business Administration from City College of New York, and is a Certified Public Accountant.

This is a major problem with this company. They have to stop this ridiculous way they get financing. They have to be deaf, dumb, and blind to not understand what this is doing to shareholder value. This stock has tanked and will remain sub penny until management changes the way it gets financing. Very disappointing!!!!

Drinks Americas Reports Profitability for 3rd Quarter and Increases Revenue 687%
Date : 03/15/2012 @ 8:00AM
Source : PR Newswire
Stock : Drinks Americas Hldg (DKAM)
Quote : 0.75 0.0 (0.00%) @ 7:37AM

Drinks Americas Reports Profitability for 3rd Quarter and Increases Revenue 687%
Drinks Americas Hldg (OTCBB:DKAM)

Today : Thursday 15 March 2012
Click Here for more Drinks Americas Hldg Charts.
Drinks Americas Reports Profitability for 3rd Quarter and Increases Revenue 687% Company Attributes Significant Increase in Demand for KAH Tequila and Cost Benefits Through the Worldwide Beverage Imports Transaction to Growth and Profitability

PR Newswire

WILTON, Conn., March 15, 2012

WILTON, Conn., March 15, 2012 /PRNewswire/ -- Drinks Americas Holdings, Ltd., ("Drinks") (OTCBB: DKAM), a leading developer and marketer of beverage products, announces its results for the third quarter for the three months ended January 31, 2012. The Company increased revenue 687% to $1,117,000 for the quarter and achieved earnings of $182,999, compared to a loss of $531,824 for the same period last year on $142,000 of revenue.

Shareholder equity increased to $2,349,641, which is up from a deficit of $4,463,368 since the beginning of the Company's fiscal year.

Management Comment:

For the Three Months Ended January 31, 2012 Compared to Three Months Ended January 31, 2011 net sales were approximately $1,117,000 compared to net sales of approximately $142,000 for the same period last year, an increase of 687%. The increase was attributable to the Company's sales of products from the Worldwide Beverage Imports (WBI) Transaction, ongoing Rheingold Beer sales, and the Company's access to production credit from the WBI deal whereby the Company is no longer impeded from production limitations due to access to capital.

Gross Margins increased 265% to $232,341, or 20.8% of net sales for the three months ended January 31, 2012, compared to gross margin of $8,086, or 5.7% of net sales for the three months ended January 31, 2011.

Selling, general and administrative expenses totaled approximately $345,000 for the three months ended January 31, 2012, compared to $662,000 for the three months ended January 31, 2011, a decrease of approximately $317,000, or 47.9%. The Company attributes this decrease to reduced overhead costs.

Interest income (expense) for the three months ended January 31, 2012 was approximately $11,000, compared to $(265,000) for the same period last year, a net decrease of $276,000, or 104%. This decrease is predominantly due to the Company's access to production capacity through the WBI transaction and a reduction in the cost of financing outstanding liabilities as compared to prior year.

For the Nine Months Ended January 31, 2012 Compared to Nine Months Ended January 31, 2010 net sales were approximately $2,536,000 compared to net sales of approximately $388,000 for the same period last year, an increase of 554%.

Gross margin increased 101% to $550,016, or 21.7% of net sales for the nine months ended January 31, 2012, compared to gross margin of $42,031, or 10.8% of net sales for the nine months ended January 31, 2011. This increase in gross margin is attributable to a higher premium product mix in the current period as compared to the same period last year.

Selling, general and administrative expenses totaled approximately $1,591,000 for the nine months ended January 31, 2012, compared to $1,988,000 for the nine months ended January 31, 2011, a decrease of approximately $397,000, or 20.0%. The decrease is attributable to the Company's cost containment initiatives and production synergies with the WBI transaction.

Interest expense for the nine months ended January 31, 2012 was approximately $157,000, compared to $734,000 for the same period last year, a net decrease of $577,000, or 79%. This decrease is predominantly due to a reduction in the cost of financing outstanding liabilities as compared to prior year.